# Providing Access to Cord Blood Units for Transplants

> **NCT01479582** · PHASE2 · WITHDRAWN · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Chronic Myelogous Leukemia/Other Leukemia
- Acute Leukemias
- MDS/MPS
- Multiple Myeloma
- Non-Hodgkin Lymphoma

## Interventions

- **DRUG:** Access to unlicensed cord blood units

## Key facts

- **NCT ID:** NCT01479582
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-10-27
- **Primary completion:** 2012-11-26
- **Final completion:** 2012-11-26
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01479582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01479582, "Providing Access to Cord Blood Units for Transplants". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01479582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*